These marker genes play diverse roles in cancer, such as promoting growth and proliferation (MYC, HIF1A, ATM), inhibiting apoptosis (MCL1, BIRC3, BCL2) and facilitating invasion (CXCR4, CD55). This evidence concerns the gene BCL2 and cancer.